KindlyMD (NAKA) Stock Price, News & Analysis

Company Overview

KindlyMD, Inc. is a healthcare company focused on providing integrated care for patients with complex medical needs, including chronic pain and substance use disorders. Its care model combines primary care, behavioral health services and medication-assisted treatment, with an emphasis on coordinated, patient-centered treatment.

The company has operated clinics in Utah and has also used telehealth and other technology-enabled services to expand access to care. KindlyMD’s services are designed to support patients through ongoing treatment and recovery rather than addressing individual medical issues in isolation.

KindlyMD became a publicly traded company through a business combination involving Nakamoto Holdings, with its common stock trading on the Nasdaq under the symbol NAKA. The company’s operations and leadership may continue to evolve as it develops its healthcare platform and expands its reach.

Key Stats

• Today's Range: $9.41 to $10.11
• 50-Day Range: $4.28 to $10.05
• 52-Week Range: $3.33 to $50.00
• Volume: 183,730 shs
• Average Volume: 226,012 shs
• Market Capitalization: $178.82 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $20.00
• Consensus Rating: Hold

KindlyMD Stock Analysis - MarketRank™

KindlyMD scored higher than 82% of companies evaluated by MarketBeat, and ranked 276th out of 855 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Hold

Consensus Rating

KindlyMD has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

KindlyMD has a consensus price target of $20.00, representing about 100.2% upside from its current price of $9.99.

Amount of Analyst Coverage

KindlyMD has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for KindlyMD are expected to grow in the coming year, from ($12.94) to ($1.91) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of KindlyMD is -0.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of KindlyMD is -0.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

KindlyMD has a P/B Ratio of 0.21. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

7.46% of the float of KindlyMD has been sold short.

Short Interest Ratio / Days to Cover

KindlyMD has a short interest ratio ("days to cover") of 5.4.

Change versus previous month

Short interest in KindlyMD has recently decreased by 2.70%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

KindlyMD does not currently pay a dividend.

Dividend Growth

KindlyMD does not have a long track record of dividend growth.

News and Social Media

• Score: 4.0 / 5
• News Sentiment: 1.42

News Sentiment

KindlyMD has a news sentiment score of 1.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for KindlyMD this week, compared to 1 article on an average week.

MarketBeat Follows

4 people have added KindlyMD to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 3.6 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $227,738.00 in company stock, which represents 0.1274% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, KindlyMD insiders have bought 3,039.34% more of their company's stock than they have sold. Specifically, they have bought $235,231.00 in company stock and sold $7,493.00 in company stock.

Percentage Held by Insiders

24.49% of the stock of KindlyMD is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

KindlyMD has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 9/27/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Financial Services
• Sub-Industry: Multi-Sector Holdings
• Current Symbol: NASDAQ:NAKA
• Previous Symbol: NASDAQ:NAKA
• CIK: 1946573
• Web: kindlymd.com
• Phone: (385) 388-8220
• Fax: N/A
• Employees: N/A
• Year Founded: 2019

Price Target and Rating

• Average Price Target for KindlyMD: $20.00
• High Price Target: $30.00
• Low Price Target: $13.00
• Potential Upside/Downside: +100.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.40
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): ($35.85)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$52.23 million
• Net Margins: -1,067.93%
• Pretax Margin: -1,123.90%
• Return on Equity: -63.45%
• Return on Assets: -41.04%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.15
• Quick Ratio: 0.15

Sales & Book Value

• Annual Sales: $1.82 million
• Price / Sales: 98.25
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $46.97 per share
• Price / Book: 0.21

Miscellaneous

• Outstanding Shares: 17,900,000
• Free Float: 13,513,000
• Market Cap: $178.82 million
• Optionable: N/A
• Beta: 15.99